<DOC>
	<DOCNO>NCT02352467</DOCNO>
	<brief_summary>The aim trial demonstrate effectiveness complete wound heal prospective , open-label , randomized trial pressure ulcer treat use Aurix standard care compare 1:1 patient receive undefined Usual Customary Care .</brief_summary>
	<brief_title>Effectiveness Aurix Therapy Pressure Ulcers</brief_title>
	<detailed_description>Pressure ulcer ( PUs ) common problem patient care setting , especially long-term acute care facility nurse home . Aurix platelet-rich plasma gel use treatment non-healing chronic wound . The result Aurix date use treat PUs promising . The aim trial demonstrate effectiveness complete wound heal prospective , open-label , randomized trial pressure ulcer treat use Aurix standard care determine time heal 16 week . Comparison make patient receive undefined Usual Customary Care 1:1 manner .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>1 . Medicare eligible 2 . ≥18 year age 3 . Ulcer pressure/shear etiology ( Stage II , III , IV , see Appendix 9 stage definition ) 4 . The large nonhealing wound , multiple wound present , single wound treat ( Index Ulcer ) locate heel , ischium , sacrum , trochanter 5 . For subject potentially multiple eligible PUs , large ulcer select Index Ulcer study . There must least 4 cm Index Ulcer ulcer ; ulcer closer 4 cm , subject enrol ( screen failure ) 6 . Debrided ulcer size 3 cm2 200 cm2 7 . Subject receive UCC care ≥ 2 week treat wound clinic 8 . Demonstrated adequate pressure relief regimen 9 . Duration ≥ 1 month first visit 10 . Subject must willing comply Protocol , assess enrol clinician . 1 . Subjects know sensitive Aurix component ( calcium chloride , thrombin , ascorbic acid ) and/or material bovine origin 2 . Stage I pressure ulcer 3 . Ulcers unstageable deep tissue morphology yet become open wound 4 . Presence another wound concurrently treat might interfere treatment index wind Aurix 5 . Ulcer PU pathophysiology ( e.g. , pure diabetic , vasculitic , radiation , rheumatoid , collagen vascular disease , venous , arterial etiology ) 6 . Patients chemotherapeutic agent malignancy wind area 7 . Subjects cognitively impair 8 . Serum albumin less 2.5 g/dL 9 . Plasma Platelet count le 100 x 109/L 10 . Hemoglobin le 10.5 g/dL 11 . Subject inadequate venous access repeat blood draw require Aurix Administration . 12 . Life expectancy &lt; 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Non Healing Wound</keyword>
</DOC>